TXG logo

10x Genomics (TXG) Cash from financing

annual CFF:

$10.91M-$2.75M(-20.16%)
December 31, 2024

Summary

  • As of today (June 2, 2025), TXG annual cash flow from financing activities is $10.91 million, with the most recent change of -$2.75 million (-20.16%) on December 31, 2024.
  • During the last 3 years, TXG annual CFF has fallen by -$24.38 million (-69.08%).
  • TXG annual CFF is now -97.67% below its all-time high of $468.91 million, reached on December 31, 2020.

Performance

TXG Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

quarterly CFF:

$422.00K-$4.09M(-90.66%)
March 31, 2025

Summary

  • As of today (June 2, 2025), TXG quarterly cash flow from financing activities is $422.00 thousand, with the most recent change of -$4.09 million (-90.66%) on March 31, 2025.
  • Over the past year, TXG quarterly CFF has dropped by -$1.22 million (-74.24%).
  • TXG quarterly CFF is now -99.91% below its all-time high of $486.97 million, reached on September 30, 2020.

Performance

TXG quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

TTM CFF:

$9.70M-$1.22M(-11.14%)
March 31, 2025

Summary

  • As of today (June 2, 2025), TXG TTM cash flow from financing activities is $9.70 million, with the most recent change of -$1.22 million (-11.14%) on March 31, 2025.
  • Over the past year, TXG TTM CFF has dropped by -$9.02 million (-48.20%).
  • TXG TTM CFF is now -98.11% below its all-time high of $514.38 million, reached on June 30, 2021.

Performance

TXG TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TXG Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-20.2%-74.2%-48.2%
3 y3 years-69.1%-82.5%-71.6%
5 y5 years-97.4%+101.3%-97.5%

TXG Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-69.1%at low-94.0%+112.4%-71.6%at low
5 y5-year-97.7%at low-99.9%+101.3%-98.1%at low
alltimeall time-97.7%at low-99.9%+101.3%-98.1%>+9999.0%

TXG Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$422.00K(-90.7%)
$9.70M(-11.1%)
Dec 2024
$10.91M(-20.2%)
$4.52M(+2795.5%)
$10.91M(-9.1%)
Sep 2024
-
$156.00K(-96.6%)
$12.01M(-26.0%)
Jun 2024
-
$4.60M(+181.0%)
$16.23M(-13.3%)
Mar 2024
-
$1.64M(-70.8%)
$18.72M(+37.0%)
Dec 2023
$13.67M(-13.6%)
$5.61M(+28.3%)
$13.67M(+4.7%)
Sep 2023
-
$4.37M(-38.4%)
$13.06M(+21.8%)
Jun 2023
-
$7.10M(-307.9%)
$10.72M(+7.4%)
Mar 2023
-
-$3.41M(-168.3%)
$9.99M(-36.9%)
Dec 2022
$15.82M(-55.2%)
$5.00M(+145.3%)
$15.82M(-19.8%)
Sep 2022
-
$2.04M(-67.9%)
$19.72M(-19.1%)
Jun 2022
-
$6.36M(+163.1%)
$24.36M(-28.8%)
Mar 2022
-
$2.42M(-72.9%)
$34.20M(-3.1%)
DateAnnualQuarterlyTTM
Dec 2021
$35.30M(-92.5%)
$8.90M(+33.2%)
$35.30M(+3.5%)
Sep 2021
-
$6.68M(-58.7%)
$34.10M(-93.4%)
Jun 2021
-
$16.19M(+360.3%)
$514.38M(+1.6%)
Mar 2021
-
$3.52M(-54.3%)
$506.24M(+8.0%)
Dec 2020
$468.91M(+13.1%)
$7.71M(-98.4%)
$468.91M(+1.9%)
Sep 2020
-
$486.97M(+5948.5%)
$460.09M(+18.3%)
Jun 2020
-
$8.05M(-123.8%)
$388.76M(+2.3%)
Mar 2020
-
-$33.82M(+2955.0%)
$379.85M(-8.4%)
Dec 2019
$414.59M(+293.5%)
-$1.11M(-100.3%)
$414.59M(-0.3%)
Sep 2019
-
$415.64M(<-9900.0%)
$415.70M(>+9900.0%)
Jun 2019
-
-$864.00K(-193.6%)
$59.00K(-93.6%)
Mar 2019
-
$923.00K
$923.00K
Dec 2018
$105.37M(+411.9%)
-
-
Dec 2017
$20.58M
-
-

FAQ

  • What is 10x Genomics annual cash flow from financing activities?
  • What is the all time high annual CFF for 10x Genomics?
  • What is 10x Genomics annual CFF year-on-year change?
  • What is 10x Genomics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for 10x Genomics?
  • What is 10x Genomics quarterly CFF year-on-year change?
  • What is 10x Genomics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for 10x Genomics?
  • What is 10x Genomics TTM CFF year-on-year change?

What is 10x Genomics annual cash flow from financing activities?

The current annual CFF of TXG is $10.91M

What is the all time high annual CFF for 10x Genomics?

10x Genomics all-time high annual cash flow from financing activities is $468.91M

What is 10x Genomics annual CFF year-on-year change?

Over the past year, TXG annual cash flow from financing activities has changed by -$2.75M (-20.16%)

What is 10x Genomics quarterly cash flow from financing activities?

The current quarterly CFF of TXG is $422.00K

What is the all time high quarterly CFF for 10x Genomics?

10x Genomics all-time high quarterly cash flow from financing activities is $486.97M

What is 10x Genomics quarterly CFF year-on-year change?

Over the past year, TXG quarterly cash flow from financing activities has changed by -$1.22M (-74.24%)

What is 10x Genomics TTM cash flow from financing activities?

The current TTM CFF of TXG is $9.70M

What is the all time high TTM CFF for 10x Genomics?

10x Genomics all-time high TTM cash flow from financing activities is $514.38M

What is 10x Genomics TTM CFF year-on-year change?

Over the past year, TXG TTM cash flow from financing activities has changed by -$9.02M (-48.20%)
On this page